These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-inflammatory drugs in the 21st century. Rainsford KD Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044 [TBL] [Abstract][Full Text] [Related]
3. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs. Hur C; Chan AT; Tramontano AC; Gazelle GS Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man. Dajani EZ; Islam K J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633 [TBL] [Abstract][Full Text] [Related]
10. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. Scheiman JM; Fendrick AM Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S23-9. PubMed ID: 16168078 [TBL] [Abstract][Full Text] [Related]
11. The murky waters of the coxibs: a review of the current state of play. Ostor AJ; Hazleman BL Inflammopharmacology; 2005; 13(4):371-80. PubMed ID: 16354390 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular complications of non-steroidal anti-inflammatory drugs. Fosslien E Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252 [TBL] [Abstract][Full Text] [Related]
13. Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future. Fiorucci S Gastroenterol Clin North Am; 2009 Jun; 38(2):315-32. PubMed ID: 19446261 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance. Borer JS; Simon LS Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S14-22. PubMed ID: 16168077 [TBL] [Abstract][Full Text] [Related]
17. Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs. Mosis G; Stijnen T; Castellsague J; Dieleman JP; van der Lei J; Stricker BH; Sturkenboom MC Arthritis Rheum; 2006 Aug; 55(4):537-42. PubMed ID: 16874797 [TBL] [Abstract][Full Text] [Related]
18. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain]. Nurmohamed MT Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1313; author reply 1313-4. PubMed ID: 17624165 [No Abstract] [Full Text] [Related]
19. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs]. van den Bemt BJ; Benraad HB; Rasker JJ Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414 [TBL] [Abstract][Full Text] [Related]
20. The COXIB experience: a look in the rearview mirror. Marnett LJ Annu Rev Pharmacol Toxicol; 2009; 49():265-90. PubMed ID: 18851701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]